ArticleEuropean journal of nuclear medicine and molecular imaging2020

Fracture risk and survival outcomes in metastatic castration-resistant prostate cancer patients sequentially treated with abiraterone acetate and RADIUM-223.

Orazio Caffo et al.PubMed ↗Publisher ↗

No numbers read from the abstract.